-
The Population Council, a New York City-based reproductive health research organization, and Sheldon Segal, PhD, distinguished scientist at the council, have been scheduled to receive the 2008 Prix Galien USA Pro Bono Humanum Award for their role in developing implantable hormone delivery systems.
-
As you move through your busy day at the clinic, how are you providing important sexually transmitted disease (STD) prevention messages to your patients? If caseload and budgetary restrictions are impeding your intentions, take a look at using a brief waiting room video intervention to complement your efforts.
-
What is your clinic's policy when it comes to getting a signed informed consent for HIV testing? By eliminating required written consent for HIV testing at the San Francisco Department of Public Health Medical Center, the average monthly rate of HIV tests has increased by 4.38 per 1,000 patient-visits, with a 67% increase (from 8.9 to 14.9) in the monthly average number of new positive HIV tests.
-
Talk with your patients about fraudulent drugs sold over the Internet as treatment for sexually transmitted diseases (STDs). The Food and Drug Administration (FDA) has issued warning letters to six U.S. companies and one foreign individual for marketing unapproved and misbranded drugs over the Internet to U.S. consumers for STD prevention and treatment.
-
If your practice includes care of those ages 45 and older, be prepared to discuss risk of sexually transmitted disease (STD) infection.
-
The woman in your next examination room tells you she has a long-term partner who has multiple sexual contacts. While she says she is concerned about protection against HIV, she admits she cannot convince her partner to use a male condom. What is your next move?
-
Add a new resource on menopause management to your clinical practice. The North American Menopause Society (NAMS) has just updated its guidelines on postmenopausal hormone therapy.
-
Regulatory review of a second human papillomavirus (HPV) vaccine has been delayed. GlaxoSmithKline has announced plans to submit additional data from its large-scale clinical trial for its vaccine candidate, Cervarix.
-
If your clinic is using oral fluid samples for rapid HIV testing, be sure to monitor for false-positive results.
-
Extending the current grace period for reinjection of the contraceptive shot depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer) from two to four weeks does not increase pregnancy risk and could increase contraceptive continuation, indicate findings from a newly published study.
